AAV Production Services

  • Research, Tox and cGMP Viral Vector manufacturing
  • Research, Tox and cGMP Plasmid manufacturing
  • DS and DP
  • Automated/Semi-Automated Aseptic Fill/Finish solutions

Our AAV Production Capabilities & Capacity

Andelyn offers innovative services that are designed to accelerate biopharmaceutical and cell & gene therapy projects through AAV vector development. We have 16+ customizable production suites ranging from 50L to 2000L suspension-based manufacturing platforms, as well as sixty 36-layer HYPERStacks per sublot. With solutions that cover the entire AAV production workflow, our mission is to accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.

Reserve GMP capacity today!

Why Choose Andelyn Biosciences for AAV Manufacturing?

With over 20 years of experience in viral vector manufacturing, Andelyn Biosciences’ platform manufacturing capabilities are paired with a mission to provide life-changing therapies for incurable diseases as well as rare disorders. By partnering with Andelyn Biosciences you ensure reliability, scalability and platform expertise to accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.